Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older

NCT05566639 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05566639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05566639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older
Lead sponsor
ModernaTX, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 14, 2022
Completion date
January 5, 2024
Enrollment
22,502 (actual)
Sites
233

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal influenza